Business description from prospectus – Vanta Bioscience is a preclinical contract research organization, offering a host of preclinical safety assessment services for clientele from Pharmaceutical, Medical Devices, Nutraceuticals, Feed Additive, Biotech, Agrochemicals, Cosmetics, and Chemical industries. In addition it also provides risk assessment services for evaluating the safety of the Active Pharmaceutical Ingredients (API), excipients, extractable and leachables including pharmaceutical impurities resulting due to manufacturing process or due to degradation of the product. VBS also provides expert services for determination of health based exposure limits (e.g. permitted daily exposure (PDE) or allowable daily exposure (ADE) including occupational exposure limits (OEL) for pharmaceutical manufacturers.
Promoters of Vanta Bioscience – Mohan Krishna Mulakala, Dopesh Raja Mulakala, Dr. Vyasmurti Madhavrao Shingatgeri, Dr. Soumya Simhadri, Shravan Chintapatla, Karishma Mulakala, Sajan Kiran Mulakala, Pradeep Chowdary, and Dr. Chandrasekhar Rao Simhadri
|
Vanta Bioscience IPO details |
|
| Subscription Dates | 25 – 27 September 2017 |
| IPO Price band | INR50 per share |
| Fresh issue | 1,512,000 shares (INR7.56 crore) |
| Offer for sale | Nil |
| Total IPO size | 1,512,000 shares (INR7.56 crore) |
| Minimum bid (lot size) | 3,000 shares |
| Face Value | INR10 per share |
| Retail Allocation | 50% |
| Listing On | BSE SME platform |
Vanta Bioscience’s financial performance – FY 2017 is the first financial year of the Company and the Company has not carried any operations during the period covered under this Restated Financial Report. Hence no profit and loss statement has been prepared.
Vanta Bioscience Limited
NO.02/G/308/G, NO.3/FF/SF/1-20-248
Umajay Complex, Rasoolpura,
Secunderabad, Hyderabad – 500 003
Phone: +91 40 6657 5454
Email: [email protected]
Website: www.vantabio.com
| Day |
Subscription (no. of times) |
| Day 1 | 0.16 |
| Day 2 | 0.31 |
| Day 3 | 1.41 |
Â
Earnings Per Share (EPS): Not available
Price/Earnings (P/E) ratio: Not available
Return on Net Worth (RONW): Not available
Net Asset Value (NAV): INR16.71 per share
Bigshare Services Private LimitedÂ
E2, Ansa Industrial Estate, Sakivihar Road,
Sakinaka, Andheri (E),
Mumbai – 400 072
Phone:Â +91 22Â 4043 0200Â
Fax:Â +91 22Â 2847Â 5201
Email:Â [email protected]
Website:Â www.bigshareonline.com
Vanta Bioscience IPO allotment status will be available on Bigshare Services’ website. Click on this link to get allotment status.
IPO Opening Date: 25 September 2017
IPO Closing Date: 27 September 2017
Listing Date: 6 October 2017
Listing Price on BSE SME: INR51.1 per share (up 2.2% from IPO price)
Closing Price on BSE SME: INR50.2 per share (up 0.4% from IPO price)
